Apyx Medical Corp - APYX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Oct 28, 2026 | SCHEDULE 13G | Philotimo Fund, LP | 3.4% | 1,425,473 | View |
| Oct 28, 2026 | SCHEDULE 13G | Philotimo Focused Growth & Income Fund | 2.0% | 855,045 | View |
| Oct 28, 2026 | SCHEDULE 13G | Kanen Wealth Management LLC | 5.4% | 2,280,518 | View |
| Oct 28, 2026 | SCHEDULE 13G | Kanen David | 5.4% | 2,280,518 | View |
| Jul 21, 2026 | SCHEDULE 13G/A | ROYCE & ASSOCIATES LP | 7.81% | 3,274,064 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.